A detailed history of Cerity Partners LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Cerity Partners LLC holds 157,729 shares of TECH stock, worth $12 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
157,729
Previous 103,595 52.26%
Holding current value
$12 Million
Previous $7.42 Million 69.82%
% of portfolio
0.03%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$70.96 - $82.35 $3.84 Million - $4.46 Million
54,134 Added 52.26%
157,729 $12.6 Million
Q2 2024

Aug 13, 2024

SELL
$62.12 - $84.15 $2.34 Million - $3.16 Million
-37,598 Reduced 26.63%
103,595 $7.42 Million
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $6.27 Million - $7.32 Million
94,988 Added 205.58%
141,193 $9.94 Million
Q4 2023

Jan 26, 2024

BUY
$52.83 - $78.22 $2.18 Million - $3.23 Million
41,244 Added 831.36%
46,205 $3.57 Million
Q3 2023

Nov 13, 2023

SELL
$67.52 - $89.42 $2.88 Million - $3.81 Million
-42,610 Reduced 89.57%
4,961 $337,000
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $438,503 - $511,151
5,945 Added 14.28%
47,571 $3.88 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $102,130 - $123,520
1,426 Added 3.55%
41,626 $3.09 Million
Q4 2022

Feb 15, 2023

BUY
$80.67 - $352.29 $2.42 Million - $10.6 Million
29,950 Added 292.2%
40,200 $3.33 Million
Q3 2022

Nov 10, 2022

BUY
$282.54 - $391.85 $232,530 - $322,492
823 Added 8.73%
10,250 $2.91 Million
Q2 2022

Aug 10, 2022

BUY
$322.67 - $449.65 $149,073 - $207,738
462 Added 5.15%
9,427 $3.27 Million
Q1 2022

Apr 25, 2022

BUY
$353.85 - $487.79 $78,908 - $108,777
223 Added 2.55%
8,965 $3.88 Million
Q4 2021

Feb 14, 2022

BUY
$456.15 - $525.06 $402,324 - $463,102
882 Added 11.22%
8,742 $4.52 Million
Q3 2021

Oct 25, 2021

BUY
$444.87 - $538.88 $214,872 - $260,279
483 Added 6.55%
7,860 $3.81 Million
Q2 2021

Aug 11, 2021

BUY
$387.35 - $450.26 $15,494 - $18,010
40 Added 0.55%
7,377 $3.32 Million
Q1 2021

Aug 11, 2021

SELL
$314.62 - $411.0 $14,472 - $18,906
-46 Reduced 0.62%
7,337 $2.8 Million
Q1 2021

May 12, 2021

BUY
$314.62 - $411.0 $2,202 - $2,877
7 Added 0.09%
7,383 $2.82 Million
Q4 2020

Feb 11, 2021

SELL
$246.9 - $321.87 $122,709 - $159,969
-497 Reduced 6.31%
7,376 $2.34 Million
Q3 2020

Nov 12, 2020

BUY
$232.22 - $282.96 $1.83 Million - $2.23 Million
7,873 New
7,873 $1.95 Million
Q2 2019

Aug 14, 2019

SELL
$188.72 - $215.43 $1.67 Million - $1.91 Million
-8,850 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$136.09 - $200.44 $41,643 - $61,334
306 Added 3.58%
8,850 $1.76 Million
Q4 2018

Feb 06, 2019

SELL
$132.75 - $203.8 $138,458 - $212,563
-1,043 Reduced 10.88%
8,544 $1.24 Million
Q3 2018

Nov 15, 2018

BUY
$147.44 - $204.11 $130,336 - $180,433
884 Added 10.16%
9,587 $1.96 Million
Q2 2018

Aug 15, 2018

BUY
$144.9 - $165.58 $1.26 Million - $1.44 Million
8,703 New
8,703 $1.29 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.99B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.